Browse > Article
http://dx.doi.org/10.4062/biomolther.2012.20.1.019

Cyclic Peptides as Therapeutic Agents and Biochemical Tools  

Joo, Sang-Hoon (Laboratory of Biochemistry, College of Pharmacy, Catholic University of Daegu)
Publication Information
Biomolecules & Therapeutics / v.20, no.1, 2012 , pp. 19-26 More about this Journal
Abstract
There are many cyclic peptides with diverse biological activities, such as antibacterial activity, immunosuppressive activity, and anti-tumor activity, and so on. Encouraged by natural cyclic peptides with biological activity, efforts have been made to develop cyclic peptides with both genetic and synthetic methods. The genetic methods include phage display, intein-based cyclic peptides, and mRNA display. The synthetic methods involve individual synthesis, parallel synthesis, as well as split-and-pool synthesis. Recent development of cyclic peptide library based on split-and-pool synthesis allows on-bead screening, in-solution screening, and microarray screening of cyclic peptides for biological activity. Cyclic peptides will be useful as receptor agonist/antagonist, RNA binding molecule, enzyme inhibitor and so on, and more cyclic peptides will emerge as therapeutic agents and biochemical tools.
Keywords
Cyclic peptides; Split-and-pool synthesis; On-bead screening; Drug lead;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Athanassiou, Z., Dias, R. L., Moehle, K., Dobson, N., Varani, G. and Robinson, J. A. (2004) Structural mimicry of retroviral tat proteins by constrained beta-hairpin peptidomimetics: ligands with high affi nity and selectivity for viral TAR RNA regulatory elements. J. Am. Chem. Soc. 126, 6906-6913.   DOI   ScienceOn
2 Athanassiou, Z., Patora, K., Dias, R. L., Moehle, K., Robinson, J. A. and Varani, G. (2007) Structure-guided peptidomimetic design leads to nanomolar beta-hairpin inhibitors of the Tat-TAR interaction of bovine immunodefi ciency virus. Biochemistry. 46, 741-751.   DOI   ScienceOn
3 Bu, X., Wu, X., Xie, G. and Guo, Z. (2002) Synthesis of tyrocidine A and its analogues by spontaneous cyclization in aqueous solution. Org. Lett. 4, 2893-2895.   DOI   ScienceOn
4 Colgrave, M. L., Korsinczky, M. J., Clark, R. J., Foley, F. and Craik, D. J. (2010) Sunflower trypsin inhibitor-1, proteolytic studies on a trypsin inhibitor peptide and its analogs. Biopolymers. 94, 665-672.   DOI   ScienceOn
5 Dubos, R. J. and Cattaneo, C. (1939) Studies on a bactericidal agent extracted from a soil bacillus : Iii. preparation and activity of a protein-free fraction. J. Exp. Med. 70, 249-256.   DOI
6 Eckert, K., Schwarz, H., Tomer, K. B. and Gross, M. L. (1985). Tandem mass spectrometry methodology for the sequence determination of cyclic peptides. J. Am. Chem. Soc. 107, 6765-6769.   DOI
7 Edman, P. (1959) Chemistry of amino acids and peptides. Annu. Rev. Biochem. 28, 69-96.   DOI   ScienceOn
8 Furka, A., Sebestyen, F., Asgedom, M. and Dibo, G. (1991) General method for rapid synthesis of multicomponent peptide mixtures. Int. J. Pept. Protein. Res. 37, 487-493.
9 Gehlsen, K. R., Argraves, W. S., Pierschbacher, M. D. and Ruoslahti, E. (1988) Inhibition of in vitro tumor cell invasion by Arg-Gly-Aspcontaining synthetic peptides. J. Cell. Biol. 106, 925-930.   DOI   ScienceOn
10 Giroux, R. (2005) Cyclosporine. Chem. Eng. News. 83, 56.   DOI
11 Gurrath, M., Müller, G., Kessler, H., Aumailley, M. and Timpl, R. (1992) Conformation/activity studies of rationally designed potent antiadhesive RGD peptides. Eur. J. Biochem. 210, 911-921.   DOI   ScienceOn
12 Hayashi, R., Tanoue, K., Durell, S. R., Chatterjee, D. K., Jenkins, L. M., Appella, D. H. and Appella, E. (2011) Optimization of a cyclic peptide inhibitor of Ser/Thr phosphatase PPM1D (Wip1). Biochemistry. 50, 4537-4549.   DOI   ScienceOn
13 Hayouka, Z., Hurevich, M., Levin, A., Benyamini, H., Iosub, A., Maes, M., Shalev, D. E., Loyter, A., Gilon, C. and Friedler, A. (2010) Cyclic peptide inhibitors of HIV-1 integrase derived from the LEDGF/p75 protein. Bioorg. Med. Chem. 18, 8388-8395.   DOI   ScienceOn
14 Hodgkin, D. C. and Oughton, B. M. (1957) Possible molecular models for gramicidin S and their relationship to present ideas of protein structure. Biochem. J. 65, 752-756.
15 Horswill, A. R., Savinov, S. N. and Benkovic, S. J. (2004) A systematic method for identifying small-molecule modulators of protein-protein interactions. Proc. Natl. Acad. Sci. USA. 101, 15591-15596.   DOI   ScienceOn
16 Houghten, R. A., Pinilla, C., Blondelle, S. E., Appel, J. R., Dooley, C. T. and Cuervo, J. H. (1991) Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery. Nature. 354, 84-86.   DOI   ScienceOn
17 Horton, D. A., Bourne, G. T. and Smythe, M. L. (2002) Exploring privileged structures: the combinatorial synthesis of cyclic peptides. J. Comput. Aided. Mol. Des. 16, 415-430.   DOI   ScienceOn
18 Hotchkiss, R. D. (1941) The chemical nature of gramicidin and tyrocidine. J. Biol. Chem. 141, 171-185.
19 Hotchkiss, R. D. and Dubos, R. J. (1941) The isolation of bactericidal substances from cultures of Bacillus brevis. J. Biol. Chem. 141, 155-162.
20 Hull, S. E., Karlsson, R., Main, P., Woolfson, M. M. and Dodson, E. J. (1978) The crystal structure of a hydrated gramicidin S-urea complex. Nature. 275, 206-207.   DOI   ScienceOn
21 Hummel, G., Reineke, U. and Reimer, U. (2006) Translating peptides into small molecules. Mol. Biosyst. 2, 499-508.   DOI   ScienceOn
22 Humphries, M. J., Olden, K. and Yamada, K. M. (1986) A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells. Science. 233, 467-470.   DOI
23 Joo, S. H., Xiao, Q., Ling, Y., Gopishetty, B. and Pei, D. (2006) Highthroughput sequence determination of cyclic peptide library members by partial Edman degradation/mass spectrometry. J. Am. Chem. Soc. 128, 13000-13009.   DOI   ScienceOn
24 Kohli, R. M., Walsh, C. T. and Burkart, M. D. (2002) Biomimetic synthesis and optimization of cyclic peptide antibiotics. Nature 418, 658-661.   DOI   ScienceOn
25 Koivunen, E., Gay, D. A. and Ruoslahti, E. (1993) Selection of peptides binding to the alpha 5 beta 1 integrin from phage display library. J. Biol. Chem. 268, 20205-20210.
26 Lam, K. S., Salmon, S. E., Hersh, E. M., Hruby, V. J., Kazmierski, W. M. and Knapp, R. J. (1991) A new type of synthetic peptide library for identifying ligand-binding activity. Nature. 354, 82-84.   DOI   ScienceOn
27 Kwon, Y. U. and Kodadek, T. (2007) Quantitative comparison of the relative cell permeability of cyclic and linear peptides. Chem. Biol. 14, 671-677.   DOI   ScienceOn
28 Kwon, Y. U. and Kodadek, T. (2008) Encoded combinatorial libraries for the construction of cyclic peptoid microarrays. Chem. Commun. (Camb). 44, 5704-5706.
29 Lalonde, M. S., Lobritz, M. A., Ratcliff, A., Chamanian, M., Athanassiou, Z., Tyagi, M., Wong, J., Robinson, J. A., Karn, J., Varani, G. and Arts, E. J. (2011) Inhibition of both HIV-1 reverse transcription and gene expression by a cyclic peptide that binds the Tattransactivating response element (TAR) RNA. PLoS. Pathog. 7, e1002038.   DOI
30 Liu, T., Joo, S. H., Voorhees, J. L., Brooks, C. L. and Pei, D. (2009) Synthesis and screening of a cyclic peptide library: discovery of small-molecule ligands against human prolactin receptor. Bioorg. Med. Chem. 17, 1026-1033.   DOI   ScienceOn
31 Liu, T., Liu, Y., Kao, H. Y. and Pei, D. (2010) Membrane permeable cyclic peptidyl inhibitors against human Peptidylprolyl Isomerase Pin1. J. Med. Chem. 53, 2494-2501.   DOI   ScienceOn
32 Loffet, A. (2002) Peptides as drugs: is there a market? J. Pept. Sci. 8, 1-7.   DOI   ScienceOn
33 Mas-Moruno, C., Rechenmacher, F. and Kessler, H. (2010) Cilengitide: the fi rst anti-angiogenic small molecule drug candidate design, synthesis and clinical evaluation. Anticancer. Agents. Med. Chem. 10, 753-768.   DOI   ScienceOn
34 Matsuzaki, K. (1999) Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. Biochim. Biophys. Acta. 1462, 1-10.   DOI   ScienceOn
35 Naumann, T. A., Tavassoli, A. and Benkovic, S. J. (2008) Genetic selection of cyclic peptide Dam methyltransferase inhibitors. Chembiochem. 9, 194-197.   DOI   ScienceOn
36 Millward, S. W., Fiacco, S., Austin, R. J. and Roberts, R. W. (2007) Design of cyclic peptides that bind protein surfaces with antibody-like affi nity. ACS. Chem. Biol. 2, 625-634.   DOI   ScienceOn
37 Millward, S. W., Takahashi, T. T. and Roberts, R. W. (2005) A general route for post-translational cyclization of mRNA display libraries. J. Am. Chem. Soc. 127, 14142-14143.   DOI   ScienceOn
38 Murphy, E. A., Majeti, B. K., Barnes, L. A., Makale, M., Weis, S. M., Lutu-Fuga, K., Wrasidlo, W. and Cheresh, D. A. (2008) Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis. Proc. Natl. Acad. Sci. USA 105, 9343-9348.   DOI   ScienceOn
39 Ngoka, L. C. and Gross, M. L. (1999) Multistep tandem mass spectrometry for sequencing cyclic peptides in an ion-trap mass spectrometer. J. Am. Soc. Mass. Spectrom. 10, 732-746.   DOI   ScienceOn
40 Noiri, E., Gailit, J., Sheth, D., Magazine, H., Gurrath, M., Muller, G., Kessler, H. and Goligorsky, M. S. (1994) Cyclic RGD peptides ameliorate ischemic acute renal failure in rats. Kidney. Int. 46, 1050-1058.   DOI   ScienceOn
41 O'Neil, K. T., Hoess, R. H., Jackson, S. A., Ramachandran, N. S., Mousa, S. A. and DeGrado, W. F. (1992) Identifi cation of novel peptide antagonists for GPIIb/IIIa from a conformationally constrained phage peptide library. Proteins. 14, 509-515.   DOI   ScienceOn
42 Park, B. W., Zhang, H. T., Wu, C., Berezov, A., Zhang, X., Dua, R., Wang, Q., Kao, G., O'Rourke, D. M., Greene, M. I. and Murali, R. (2000) Rationally designed anti-HER2/neu peptide mimetic disables P185HER2/neu tyrosine kinases in vitro and in vivo. Nat. Biotechnol. 18, 194-198.   DOI   ScienceOn
43 Perler, F. B. (2005) Protein splicing mechanisms and applications. IUBMB. Life. 57, 469-476.   DOI   ScienceOn
44 Redman, J. E., Wilcoxen, K. M. and Ghadiri, M. R. (2003) Automated mass spectrometric sequence determination of cyclic peptide library members. J. Comb. Chem. 5, 33-40.   DOI   ScienceOn
45 Perler, F. B, Davis, E. O., Dean, G. E., Gimble, F. S., Jack, W. E., Neff, N., Noren, C. J., Thorner, J. and Belfort, M. (1994) Protein splicing elements: inteins and exteins--a defi nition of terms and recommended nomenclature. Nucleic. Acids. Res. 22, 1125-1127.   DOI   ScienceOn
46 Qin, C., Bu, X., Zhong, X., Ng, N. L. and Guo, Z. (2004) Optimization of antibacterial cyclic decapeptides. J. Comb. Chem. 6, 398-406.   DOI   ScienceOn
47 Qin, C., Zhong, X., Bu, X., Ng, N. L. and Guo, Z. (2003) Dissociation of antibacterial and hemolytic activities of an amphipathic peptide antibiotic. J. Med. Chem. 46, 4830-4833.   DOI   ScienceOn
48 Rezai, T., Yu, B., Millhauser, G. L., Jacobson, M. P. and Lokey, R. S. (2006) Testing the conformational hypothesis of passive membrane permeability using synthetic cyclic peptide diastereomers. J. Am. Chem. Soc. 128, 2510-2511.   DOI   ScienceOn
49 Roberts, R. W. and Szostak, J. W. (1997) RNA-peptide fusions for the in vitro selection of peptides and proteins. Proc. Natl. Acad. Sci. USA 94, 12297-12302.   DOI   ScienceOn
50 Schilling, B., Wang, W., McMurray, J.S. and Medzihradszky, K.F. (1999) Fragmentation and sequencing of cyclic peptides by matrixassisted laser desorption/ionization post-source decay mass spectrometry. Rapid. Commun. Mass. Spectrom. 13, 2174-2179.   DOI   ScienceOn
51 Scott, C. P., Abel-Santos, E., Wall, M., Wahnon, D. C. and Benkovic, S. J. (1999) Production of cyclic peptides and proteins in vivo. Proc. Natl. Acad. Sci. USA 96, 13638-13643.   DOI   ScienceOn
52 Siegel, M. M., Huang, J., Lin, B., Tsao, R. and Edmonds, C. G. (1994) Structures of bacitracin A and isolated congeners: sequencing of cyclic peptides with blocked linear side chains by electrospray ionization mass spectrometry. Biol. Mass. Spectrom. 23, 186-204.   DOI   ScienceOn
53 Synge, R. L. (1945) 'Gramicidin S': over-all chemical characteristics and amino-acid composition. Biochem. J. 39, 363-367.
54 Smith, G. P. (1985) Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science. 228, 1315-1317.   DOI
55 Stauch, B., Simon, B., Basile, T., Schneider, G., Malek, N. P., Kalesse, M. and Carlomagno, T. (2010) Elucidation of the structure and intermolecular interactions of a reversible cyclic-peptide inhibitor of the proteasome by NMR spectroscopy and molecular modeling. Angew. Chem. Int. Ed. Engl. 49, 3934-3938.   DOI   ScienceOn
56 Sweeney, M. C. and Pei, D. (2003) An improved method for rapid sequencing of support-bound peptides by partial edman degradation and mass spectrometry. J. Comb. Chem. 5, 218-222.   DOI   ScienceOn
57 Tamamura, H., Tsutsumi, H., Masuno, H., Mizokami, S., Hiramatsu, K., Wang, Z., Trent, J. O., Nakashima, H., Yamamoto, N., Peiper, S. C. and Fujii, N. (2006) Development of a linear type of low molecular weight CXCR4 antagonists based on T140 analogs. Org. Biomol. Chem. 4, 2354-2357.   DOI   ScienceOn
58 Tamamura, H., Xu, Y., Hattori, T., Zhang, X., Arakaki, R., Kanbara, K., Omagari, A., Otaka, A., Ibuka, T., Yamamoto, N., Nakashima, H. and Fujii, N. (1998) A low-molecular-weight inhibitor against the chemokine receptor CXCR4: a strong anti-HIV peptide T140. Biochem. Biophys. Res. Commun. 253, 877-882.   DOI   ScienceOn
59 Tavassoli. A., Benkovic, S. J. (2005) Genetically selected cyclic-peptide inhibitors of AICAR transformylase homodimerization. Angew. Chem. Int. Ed. Engl. 44, 2760-2763.   DOI   ScienceOn
60 Tavassoli, A., Lu, Q., Gam, J., Pan, H., Benkovic, S. J. and Cohen, S. N. (2008) Inhibition of HIV budding by a genetically selected cyclic peptide targeting the Gag-TSG101 interaction. ACS. Chem. Biol. 3, 757-764.   DOI   ScienceOn
61 Xiao, Q. and Pei, D. (2007) High-throughput synthesis and screening of cyclic peptide antibiotics. J. Med. Chem. 50, 3132-3137.   DOI   ScienceOn
62 Thakkar. A., Wavreille. A.S. and Pei, D. (2006) Traceless capping agent for peptide sequencing by partial edman degradation and mass spectrometry. Anal. Chem. 78, 5935-5939.   DOI   ScienceOn
63 Vlieghe, P., Lisowski, V., Martinez, J. and Khrestchatisky, M. (2010) Synthetic therapeutic peptides: science and market. Drug. Discov. Today. 15, 40-56.   DOI   ScienceOn
64 Wenger, R. M. (1984) Synthesis of cycosporine. Total syntheses of 'cyclosporin A' and 'cyclosporin H', two fungal metabolites isolated from the species. Tolypocladium infl atum GAMS. Helvetica. Chimica. Acta. 67, 502-525.   DOI
65 Zasloff, M. (2002) Antimicrobial peptides of multicellular organisms. Nature. 415, 389-395.   DOI   ScienceOn